Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA issues warning on AbbVie hep C drugs and drugmaker's shares fall 10%
FDA issues warning on AbbVie hep C drugs and drugmaker's shares fall 10%
FDA issues warning on AbbVie hep C drugs and drugmaker's shares fall 10%
Submitted by
admin
on October 22, 2015 - 7:30pm
Source:
Fierce Pharma
News Tags:
FDA
hepatitis C
AbbVie
liver damage
Technivie
Viekira Pak
Headline:
FDA issues warning on AbbVie hep C drugs and drugmaker's shares fall 10%
Do Not Allow Advertisers to Use My Personal information
